Global Pharmaceuticals & Biotech Profitable Climbers

Zevra Therapeutics

Market Cap: US$556.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Clinuvel Pharmaceuticals

Market Cap: AU$456.3m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$44.7b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Rubicon Research

Market Cap: ₹135.1b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Camurus

Market Cap: SEK 30.8b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bora Pharmaceuticals

Market Cap: NT$53.6b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Bonesupport Holding

Market Cap: SEK 15.8b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

PharmaEssentia

Market Cap: NT$240.1b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Neuren Pharmaceuticals

Market Cap: AU$1.5b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

ChengDu ShengNuo BiotecLtd

Market Cap: CN¥5.9b

Engages in the research and development, production, sale, and export of peptide drugs.

Acutaas Chemicals

Market Cap: ₹196.0b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Bio SolutionLtd

Market Cap: ₩306.3b

Develops, manufactures, and sells cell therapy products worldwide.

WuXi XDC Cayman

Market Cap: HK$77.6b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Aether Industries

Market Cap: ₹157.3b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Abeona Therapeutics

Market Cap: US$280.1m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

SKAN Group

Market Cap: CHF 1.0b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$42.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Soleno Therapeutics

Market Cap: US$2.7b

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Pharma Mar

Market Cap: €1.6b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م8.9b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

XtalPi Holdings

Market Cap: HK$41.1b

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

Orchid Pharma

Market Cap: ₹27.7b

A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.

CORONA Remedies

Market Cap: ₹96.5b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

Innova Captab

Market Cap: ₹39.7b

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.

May & Baker Nigeria

Market Cap: ₦59.3b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

Cohance Lifesciences

Market Cap: ₹137.2b

Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.

Oncodesign Precision Medicine Société anonyme

Market Cap: €8.8m

A biopharmaceutical company, engages in the precision medicine business.

Kiniksa Pharmaceuticals International

Market Cap: US$3.6b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Emcure Pharmaceuticals

Market Cap: ₹309.1b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Senores Pharmaceuticals

Market Cap: ₹38.6b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Viyash Scientific

Market Cap: ₹89.8b

Operates in the veterinary healthcare business in Europe, Asia, and internationally.

Labiana Health

Market Cap: €38.7m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.

XOMA Royalty

Market Cap: US$437.8m

Operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia.

SIGA Technologies

Market Cap: US$312.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Kuros Biosciences

Market Cap: CHF 984.1m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Shanghai OPM Biosciences

Market Cap: CN¥6.8b

Provides cell culture media and CDMO services in China and internationally.